R-1627

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameR-1627
Drug Alias NameR-1627
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A